Table 2 Risk factors associated with molecular recurrence.

From: Treatment of cytomegalovirus anterior segment infection with intravitreal injection of ganciclovir in adjunction with or without oral valganciclovir: a long-term results

Variable

Univariate analysis

Multivariate analysis

HR (95% CI)

P

HR (95% CI)

P

Demographics

Age, year

1.04 (0.99–1.09)

0.139

1.01 (0.96–1.07)

0.526

Male

1.43 (0.42–4.92)

0.572

  

Prior to diagnosis

Topical antiviral use

0.47 (0.09–2.55)

0.381

  

Glaucoma surgery

0.75 (0.13–4.45)

0.752

  

Cataract surgery

2.63 (0.88–7.90)

0.084

1.44 (0.39–5.35)

0.587

Corneal transplant

8.75 (1.67–45.95)

0.010

6.81 (1.21–38.23)

0.029

At diagnosis

Cornea edema

1.33 (0.47–3.74)

0.593

  

Coin shaped KP

1.32 (0.46–3.79)

0.607

  

AC inflammation

1.22 (0.41–3.58)

0.721

  

IOP, mmHg

1.00 (0.95–1.07)

0.858

  
  1. HR hazard ratio, CI confidence interval, KP keratic precipitates, IOP intraocular pressure, AC anterior chamber.
Back to article page